However, the expression levels were not associated with the clinical outcomes of colorectal adenocarcinoma patients, suggesting that hnRNPA2B1/C/D/F were not distinct prognostic biomarkers in colorectal adenocarcinoma. The gene discussed is HNRNPA2B1; the disease is colorectal adenocarcinoma.